Skip to main content
. 2022 Jun 3;7(3):V. doi: 10.1177/23969873221099736

Table 3.

Baseline characteristics of participants in the studies included in the quantitative analysis performed for PICO 2.

Study Study design Treatment Participants (n) Women (%) Aneurysm size range (mm) Periprocedural stroke
Wiebers et al. 24 a Observational No treatment, EVT, MST 4060 76 2–≥25 mm (range) MST: 286/1917
EVT: 36/451
Brilstra et al. 35 Observational EVT, MST 51 75 0–>25 (range) MST: 11/32
EVT: 3/19
Gallas et al. 36 Observational EVT 302 63 NA b EVT: 36/302
Guglielmi detachable coils
Gentric et al. 37 Observational EVT 107 69 NA c EVT: 6/107
Stent assisted coilling
Hetts et al. 38 Observational EVT 361 77 4–20 (range) EVT: 22/361
Stent assisted coil, simple coil
Poncyljusz et al. 39 Observational EVT 78 73 NA
LVIS and LVIS Jr. stents
Darsaut et al. 27 RCT EVT, MST 136 69 3–25 (range) MST: 3/65
EVT: 7/69
Pumar et al. 40 Observational EVT 104 75 <10 mm EVT: 7/104
SILK flow diverter
Hanel et al. 41 Observational EVT 141 88 ≤12 mm d
Pipeline embolisation device for wide necked aneurysms

EVT: endovascular treatment; MST: microsurgical treatment; NA: not available; RCT: randomised controlled trial.

a

A small proportion of patients had an associated condition, such as arteriovenous malformation (2.0%) or polycystic kidney disease (1.6%).

b

Aneurysms <10 mm represented 77% of the participants.

c

Aneurysms <6 mm represented 52% of the participants.

d

Aneurysms 7 to 12 mm represented 16% of the participants.